Doreen McMorran
Founder en OVATION SCIENCE INC. .
Fortuna: 137 663 $ al 31/03/2024
Perfil
Doreen McMorran founded Ovation Science, Inc. (Canada) in 2017, where she is working as CFO, COO & Independent Director from 2023.
Ms. McMorran also currently works at Skinvisible, Inc., as Head-Business Development & Marketing and Skinvisible Pharmaceuticals, Inc., as Vice President-Business Development from 2008.
Ms. McMorran received her undergraduate degree from the University of Manitoba.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
OVATION SCIENCE, INC.
13.15% | 30/10/2023 | 3 862 250 ( 13.15% ) | 135 179 $ | 31/03/2024 |
SKINVISIBLE, INC.
0.79% | 12/03/2024 | 36 000 ( 0.79% ) | 2 484 $ | 31/03/2024 |
Cargos activos de Doreen McMorran
Empresas | Cargo | Inicio |
---|---|---|
SKINVISIBLE, INC. | Public Communications Contact | - |
OVATION SCIENCE INC. | Founder | 18/07/2017 |
Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Skinvisible, Inc., Skinvisible Pharmaceuticals, Inc. researches, develops, and manufactures pharmaceutical products for skin cancer. The private company is based in Las Vegas, NV. | Corporate Officer/Principal | 01/04/2008 |
Formación de Doreen McMorran.
University of Manitoba | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Skinvisible, Inc. | |
Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Skinvisible, Inc., Skinvisible Pharmaceuticals, Inc. researches, develops, and manufactures pharmaceutical products for skin cancer. The private company is based in Las Vegas, NV. | Commercial Services |
Ovation Science, Inc. (Canada) |
- Bolsa de valores
- Insiders
- Doreen McMorran